The World Health Organization (WHO) has raised an alarm regarding nearly nine million individuals who currently lack access to critical HIV treatment. According to a new assessment presented at the 26th International AIDS Conference in Rio de Janeiro, dwindling financial support, humanitarian turmoil, and persistent social disparities could jeopardize international goals to eliminate HIV, hepatitis, and other sexually transmitted infections (STIs) by 2030.
Dr. Tedros Adhanom Ghebreyesus, the WHO Director-General, noted that the report highlights a split in global outcomes. While scientific advancements and strategic investments have yielded positive results—including a 42 percent drop in new HIV infections and a 57 percent decrease in AIDS-related deaths since 2010—these achievements remain precarious. Recent cuts in donor funding during 2025 have already hindered vital prevention initiatives, such as the distribution of pre-exposure prophylaxis (PrEP).
The agency also spotlighted the ongoing crisis of viral hepatitis, which remains a leading cause of death globally. Although hepatitis B infections have trended downward, the disease still caused roughly 1.3 million fatalities in 2024. Furthermore, the report pointed to rising STI cases and the growing threat of antimicrobial resistance, particularly regarding gonorrhea.
To regain momentum, the WHO is advocating for the integration of HIV, hepatitis, and STI services into primary healthcare systems. By leveraging digital technology, improving disease surveillance, and ensuring fair access to innovative tools like injectable lenacapavir, the agency believes countries can better support vulnerable populations. Dr. Tereza Kasaeva, head of the WHO’s department for these diseases, framed the report as a vital roadmap for the final years of the 2030 strategy, urging nations to prioritize community leadership and data-driven accountability.
